The SGC is governed by a Board of Directors, composed of representatives from our major funders, and Scientific Committees that provide direction to our research activities.

The SGC is overseen by its CEO, Aled Edwards. Each of the SGC labs is directed by a Chief Scientist.

SGC Board

Anke Müller-Fahrnow (Chair), ICB Nuvisan
Ulrich Betz, Merck KGaA, Darmstadt, Germany
Oliver Kraemer, Boehringer Ingelheim
Kumar Saikatendu, Takeda
Sujata Sharma, Janssen
Dafydd Owen, Pfizer
Judith Günther, Bayer Pharma
Susanne Müller-Knapp (Secretary), SGC-Frankfurt

SGC Management Team

Aled Edwards CEO 
Susan McCormick CFO
Max Morgan, General Legal Counsel and Director of Public Policy
Cheryl Arrowsmith, CSO SGC-Toronto
Stefan Knapp, CSO SGC-Frankfurt
Michael Sundström, CSO SGC-Karolinska
Timothy Willson, CSO SGC-UNC
Ted Fon, CSO SGC-Neuro

Chemical Probes

Scientific Committee

Ched Grimshaw, Ched Grimshaw Consulting, LLC (Chair)
Lindsey Ingerman, University of North Carolina
Paul Thompson University of Massachusetts
Jolanta Grembeka University of Michigan

Joint Management Committee

Hartmut Beck Bayer Sujata Sharma Janssen Kumar Saikatendu Takeda
James Kiefer Genentech Dafydd Owen Pfizer Jark Böettcher Boehringer Ingelheim


glqxz9283 sfy39587stf02 mnesdcuix8